102 related articles for article (PubMed ID: 7606199)
21. Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent.
Gupta E; Olopade OI; Ratain MJ; Mick R; Baker TM; Berezin FK; Benson AB; Dolan ME
Clin Cancer Res; 1995 Oct; 1(10):1133-8. PubMed ID: 9815904
[TBL] [Abstract][Full Text] [Related]
22. Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis.
Morgan RJ; Newman EM; Doroshow JH; McGonigle K; Margolin K; Raschko J; Chow W; Somlo G; Leong L; Tetef M; Shibata S; Hamasaki V; Carroll M; Vasilev S; Akman S; Coluzzi P; Wagman L; Longmate J; Paz B; Yen Y; Klevecz R
Cancer Res; 1998 Jul; 58(13):2793-800. PubMed ID: 9661893
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
24. Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer.
Caponigro F; Avallone A; McLeod H; Cartenì G; De Vita F; Casaretti R; Morsman J; Blackie R; Budillon A; De Lucia L; Gravina A; Catalano G; Comella P; Comella G
Clin Cancer Res; 1999 Dec; 5(12):3948-55. PubMed ID: 10632324
[TBL] [Abstract][Full Text] [Related]
25. [Effect of N-acetylcysteine on the egg granuloma in hepatic tissue of mice with Schistosomosis japonica].
Fan ZG; Zhang LM; Li KJ; Li W; Zhu PX; Yang G
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Apr; 25(2):137-40. PubMed ID: 17633826
[TBL] [Abstract][Full Text] [Related]
26. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA
Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
[TBL] [Abstract][Full Text] [Related]
27. Phase I study to determine the safety and pharmacokinetics of oral administration of TAS-102 in patients with solid tumors.
Hong DS; Abbruzzese JL; Bogaard K; Lassere Y; Fukushima M; Mita A; Kuwata K; Hoff PM
Cancer; 2006 Sep; 107(6):1383-90. PubMed ID: 16902987
[TBL] [Abstract][Full Text] [Related]
28. Ellagic acid, a natural polyphenol protects rat peripheral blood lymphocytes against nicotine-induced cellular and DNA damage in vitro: with the comparison of N-acetylcysteine.
Sudheer AR; Muthukumaran S; Devipriya N; Menon VP
Toxicology; 2007 Jan; 230(1):11-21. PubMed ID: 17188416
[TBL] [Abstract][Full Text] [Related]
29. Phase I study of TLK286 (glutathione S-transferase P1-1 activated glutathione analogue) in advanced refractory solid malignancies.
Rosen LS; Brown J; Laxa B; Boulos L; Reiswig L; Henner WD; Lum RT; Schow SR; Maack CA; Keck JG; Mascavage JC; Dombroski JA; Gomez RF; Brown GL
Clin Cancer Res; 2003 May; 9(5):1628-38. PubMed ID: 12738715
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administration of alkylators, with or without glutathione depletion in a rat model.
Neuwelt EA; Pagel MA; Hasler BP; Deloughery TG; Muldoon LL
Cancer Res; 2001 Nov; 61(21):7868-74. PubMed ID: 11691805
[TBL] [Abstract][Full Text] [Related]
31. The toxicity of N-methyl-alpha-methyldopamine to freshly isolated rat hepatocytes is prevented by ascorbic acid and N-acetylcysteine.
Carvalho M; Remião F; Milhazes N; Borges F; Fernandes E; Carvalho F; Bastos ML
Toxicology; 2004 Aug; 200(2-3):193-203. PubMed ID: 15212815
[TBL] [Abstract][Full Text] [Related]
32. Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance.
Glaze ER; Lambert AL; Smith AC; Page JG; Johnson WD; McCormick DL; Brown AP; Levine BS; Covey JM; Egorin MJ; Eiseman JL; Holleran JL; Sausville EA; Tomaszewski JE
Cancer Chemother Pharmacol; 2005 Dec; 56(6):637-47. PubMed ID: 15986212
[TBL] [Abstract][Full Text] [Related]
33. [The clinical phase I study of TNP-351. The TNP-351 Research Committee].
Taguchi T; Niitani H; Furue H; Tsukagoshi S; Kanamaru R; Hasegawa K; Akazawa S; Yoneda S; Tominaga T; Sasaki T
Gan To Kagaku Ryoho; 1995 Feb; 22(2):259-71. PubMed ID: 7857102
[TBL] [Abstract][Full Text] [Related]
34. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
[TBL] [Abstract][Full Text] [Related]
35. Intravenous Administration of Stable-Labeled N-Acetylcysteine Demonstrates an Indirect Mechanism for Boosting Glutathione and Improving Redox Status.
Zhou J; Coles LD; Kartha RV; Nash N; Mishra U; Lund TC; Cloyd JC
J Pharm Sci; 2015 Aug; 104(8):2619-26. PubMed ID: 26052837
[TBL] [Abstract][Full Text] [Related]
36. No penetration of orally administered N-acetylcysteine into bronchoalveolar lavage fluid.
Cotgreave IA; Eklund A; Larsson K; Moldéus PW
Eur J Respir Dis; 1987 Feb; 70(2):73-7. PubMed ID: 3817074
[TBL] [Abstract][Full Text] [Related]
37. Can N-acetyl-L-cysteine affect zinc metabolism when used as a paracetamol antidote?
Brumas V; Hacht B; Filella M; Berthon G
Agents Actions; 1992 Jul; 36(3-4):278-88. PubMed ID: 1529808
[TBL] [Abstract][Full Text] [Related]
38. Human pharmacokinetics of erythromycin propionate-N-acetylcysteinate: comparative evaluation with erythromycin stearate and N-acetylcysteine.
De Bernardi M; Feletti F; Gazzani G; Fregnan GB
Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):444-7. PubMed ID: 3198299
[TBL] [Abstract][Full Text] [Related]
39. Dose dependent pharmacokinetics of N-acetylcysteine after oral dosing to man.
Borgström L; Kågedal B
Biopharm Drug Dispos; 1990 Mar; 11(2):131-6. PubMed ID: 2328298
[TBL] [Abstract][Full Text] [Related]
40. Safety and pharmacokinetic studies of liposomal antioxidant formulations containing N-acetylcysteine, α-tocopherol or γ-tocopherol in beagle dogs.
Alipour M; Mitsopoulos P; Smith MG; Bolger G; Pucaj K; Suntres ZE
Toxicol Mech Methods; 2013 Jul; 23(6):419-31. PubMed ID: 23384394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
